Financials Microalliance Group Inc.

Equities

MALG

US35069H2058

Pharmaceuticals

Market Closed - OTC Markets 08:31:30 26/12/2023 pm IST 5-day change 1st Jan Change
0.0601 USD -7.54% Intraday chart for Microalliance Group Inc. -.--% -.--%

Valuation

Fiscal Period: December 2021
Capitalization 1 920.1
Enterprise Value (EV) 1 919
P/E ratio 55.9 x
Yield -
Capitalization / Revenue 2,46,04,807 x
EV / Revenue 2,45,75,216 x
EV / EBITDA 28 x
EV / FCF -12,41,01,964 x
FCF Yield -0%
Price to Book 32.6 x
Nbr of stocks (in thousands) 6,09,316
Reference price 2 1.510
Announcement Date 31/03/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021
Net sales - 2.107 1.194 37.39
EBITDA 1 -0.0387 -0.2611 -0.5843 32.78
EBIT 1 -0.0393 -0.2858 -0.6099 32.69
Operating Margin - -13.56% -51.06% 87.43%
Earnings before Tax (EBT) 1 -0.0393 -0.2992 -0.6082 24.86
Net income 1 -0.0393 -0.3051 -0.6279 18.68
Net margin - -14.48% -52.57% 49.94%
EPS - -0.000305 -0.001046 0.0270
Free Cash Flow - 0.1504 0.2883 -7.405
FCF margin - 7.14% 24.14% -19.8%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 03/02/21 03/02/21 31/03/22 31/03/22
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021
Net Debt 1 0.07 0.59 0.32 -
Net Cash position 1 - - - 1.11
Leverage (Debt/EBITDA) -1.756 x -2.262 x -0.5505 x -
Free Cash Flow - 0.15 0.29 -7.4
ROE (net income / shareholders' equity) - 167% 91.7% 137%
ROA (Net income/ Total Assets) - -28.1% -35.8% 128%
Assets 1 - 1.086 1.753 14.61
Book Value Per Share - -0 -0 0.0500
Cash Flow per Share - 0 0 0
Capex 1 0 0.11 0 0.12
Capex / Sales - 5.26% 0.23% 0.32%
Announcement Date 03/02/21 03/02/21 31/03/22 31/03/22
1USD in Million
Estimates
  1. Stock Market
  2. Equities
  3. MALG Stock
  4. Financials Microalliance Group Inc.